Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors

MLA

Armando A. Genazzani, et al. “Oxaliplatin-Induced Neuropathy Occurs through Impairment of Haemoglobin Proton Buffering and Is Reversed by Carbonic Anhydrase Inhibitors.” Pain, vol. 161, no. 2, Oct. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....507f0952e88f53d491c02832cfec1284&authtype=sso&custid=ns315887.

APA

Armando A. Genazzani, Elisa Ballarini, Alberto Potenzieri, Alessia Chiorazzi, Beatrice Riva, Guido Cavaletti, Eleonora Pozzi, & Roberta Rigolio. (2019). Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors. Pain, 161(2).

Chicago

Armando A. Genazzani, Elisa Ballarini, Alberto Potenzieri, Alessia Chiorazzi, Beatrice Riva, Guido Cavaletti, Eleonora Pozzi, and Roberta Rigolio. 2019. “Oxaliplatin-Induced Neuropathy Occurs through Impairment of Haemoglobin Proton Buffering and Is Reversed by Carbonic Anhydrase Inhibitors.” Pain 161 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....507f0952e88f53d491c02832cfec1284&authtype=sso&custid=ns315887.